questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Interleukines
Interleukine-27
Interleukine-27 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Transcranial Magnetic Stimulation
Diagnostic
5
Interleukine-27
Cytokines
Cytométrie en flux
Tests immunologiques
Maladies auto-immunes
Inflammation
Inflammation
Gravité des maladies
Symptômes
5
Douleurs articulaires
Maladies inflammatoires
Symptômes respiratoires
Maladies pulmonaires
Symptômes neurologiques
Conditions neurologiques
Prévention
5
Modes de vie sains
Gestion du stress
Alimentation
Inflammation
Exercice physique
Santé immunitaire
Traitements
5
Thérapies biologiques
Maladies auto-immunes
Médicaments anti-inflammatoires
Modulation
Efficacité des traitements
Réponse immunitaire
Complications
5
Complications
Maladies auto-immunes
Maladies chroniques
Arthrite
Cancer
Croissance tumorale
Troubles neurologiques
Sclérose en plaques
Facteurs de risque
5
Maladies auto-immunes
Facteurs de risque
Alimentation
Régimes alimentaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interleukine-27 : Questions médicales les plus fréquentes",
"headline": "Interleukine-27 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interleukine-27 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interleukine-27"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Interleukines",
"url": "https://questionsmedicales.fr/mesh/D007378",
"about": {
"@type": "MedicalCondition",
"name": "Interleukines",
"code": {
"@type": "MedicalCode",
"code": "D007378",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.465"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interleukine-27",
"alternateName": "Interleukin-27",
"code": {
"@type": "MedicalCode",
"code": "D064094",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cory M Robinson",
"url": "https://questionsmedicales.fr/author/Cory%20M%20Robinson",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States."
}
},
{
"@type": "Person",
"name": "Tomozumi Imamichi",
"url": "https://questionsmedicales.fr/author/Tomozumi%20Imamichi",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA."
}
},
{
"@type": "Person",
"name": "Jessica M Povroznik",
"url": "https://questionsmedicales.fr/author/Jessica%20M%20Povroznik",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States."
}
},
{
"@type": "Person",
"name": "Jordan K Vance",
"url": "https://questionsmedicales.fr/author/Jordan%20K%20Vance",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States."
}
},
{
"@type": "Person",
"name": "Xiaojun Hu",
"url": "https://questionsmedicales.fr/author/Xiaojun%20Hu",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Novel ways to modulate the vestibular system: Magnetic vestibular stimulation, deep brain stimulation and transcranial magnetic stimulation / transcranial direct current stimulation.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36621040",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jns.2023.120544"
}
},
{
"@type": "ScholarlyArticle",
"name": "Noninvasive Brain Stimulation Techniques for Treatment-Resistant Depression: Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/37149347",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psc.2023.02.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Transcranial Magnetic Stimulation for the Treatment of Chemo Brain.",
"datePublished": "2023-09-22",
"url": "https://questionsmedicales.fr/article/37836847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23198017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder.",
"datePublished": "2022-12-26",
"url": "https://questionsmedicales.fr/article/36740349",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psc.2022.10.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Precise motor mapping with transcranial magnetic stimulation.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36460808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41596-022-00776-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Interleukines",
"item": "https://questionsmedicales.fr/mesh/D007378"
},
{
"@type": "ListItem",
"position": 6,
"name": "Interleukine-27",
"item": "https://questionsmedicales.fr/mesh/D064094"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interleukine-27 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interleukine-27",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interleukine-27",
"description": "Comment mesurer l'IL-27 dans le sang ?\nQuels tests sont utilisés pour évaluer l'IL-27 ?\nL'IL-27 est-elle mesurée dans des maladies spécifiques ?\nQuels biomarqueurs sont associés à l'IL-27 ?\nL'IL-27 peut-elle être un indicateur de gravité ?",
"url": "https://questionsmedicales.fr/mesh/D064094?mesh_terms=Transcranial+Magnetic+Stimulation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interleukine-27",
"description": "Quels symptômes sont liés à une élévation de l'IL-27 ?\nL'IL-27 est-elle liée à des douleurs articulaires ?\nQuels signes cliniques sont associés à l'IL-27 ?\nL'IL-27 influence-t-elle les symptômes respiratoires ?\nY a-t-il des symptômes neurologiques liés à l'IL-27 ?",
"url": "https://questionsmedicales.fr/mesh/D064094?mesh_terms=Transcranial+Magnetic+Stimulation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interleukine-27",
"description": "Peut-on prévenir l'élévation de l'IL-27 ?\nY a-t-il des vaccins liés à l'IL-27 ?\nComment l'alimentation influence-t-elle l'IL-27 ?\nL'exercice physique affecte-t-il l'IL-27 ?\nLe sommeil influence-t-il l'IL-27 ?",
"url": "https://questionsmedicales.fr/mesh/D064094?mesh_terms=Transcranial+Magnetic+Stimulation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interleukine-27",
"description": "Quels traitements ciblent l'IL-27 ?\nL'IL-27 peut-elle être inhibée ?\nQuels médicaments affectent l'IL-27 ?\nL'IL-27 est-elle une cible pour l'immunothérapie ?\nComment l'IL-27 influence-t-elle les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D064094?mesh_terms=Transcranial+Magnetic+Stimulation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interleukine-27",
"description": "Quelles complications sont liées à l'IL-27 ?\nL'IL-27 est-elle impliquée dans des maladies chroniques ?\nComment l'IL-27 affecte-t-elle le cancer ?\nY a-t-il des risques d'infection liés à l'IL-27 ?\nL'IL-27 est-elle liée à des troubles neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D064094?mesh_terms=Transcranial+Magnetic+Stimulation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interleukine-27",
"description": "Quels facteurs augmentent l'IL-27 ?\nL'âge influence-t-il les niveaux d'IL-27 ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe tabagisme affecte-t-il l'IL-27 ?\nY a-t-il un lien entre l'IL-27 et l'alimentation ?",
"url": "https://questionsmedicales.fr/mesh/D064094?mesh_terms=Transcranial+Magnetic+Stimulation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer l'IL-27 dans le sang ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-27 peut être mesurée par des tests ELISA dans des échantillons de sérum."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'IL-27 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests immunologiques comme l'ELISA et la cytométrie en flux sont utilisés."
}
},
{
"@type": "Question",
"name": "L'IL-27 est-elle mesurée dans des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-27 est souvent mesurée dans des maladies auto-immunes et inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à l'IL-27 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-27 est souvent associée à d'autres cytokines comme l'IL-6 et l'IL-10."
}
},
{
"@type": "Question",
"name": "L'IL-27 peut-elle être un indicateur de gravité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés d'IL-27 peuvent indiquer une inflammation sévère."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une élévation de l'IL-27 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une élévation de l'IL-27 peut entraîner des symptômes d'inflammation comme la fièvre."
}
},
{
"@type": "Question",
"name": "L'IL-27 est-elle liée à des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-27 peut contribuer à des douleurs articulaires dans les maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à l'IL-27 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes cliniques incluent fatigue, douleurs et symptômes systémiques d'inflammation."
}
},
{
"@type": "Question",
"name": "L'IL-27 influence-t-elle les symptômes respiratoires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-27 peut exacerber les symptômes respiratoires dans certaines maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés à l'IL-27 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés d'IL-27 peuvent être associés à des symptômes neurologiques dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'élévation de l'IL-27 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des modes de vie sains et une gestion du stress peuvent aider à prévenir l'élévation de l'IL-27."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins liés à l'IL-27 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiquement ciblant l'IL-27."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle l'IL-27 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation anti-inflammatoire peut aider à réguler les niveaux d'IL-27."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il l'IL-27 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire les niveaux d'IL-27 et améliorer la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Le sommeil influence-t-il l'IL-27 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sommeil adéquat est crucial pour maintenir des niveaux sains d'IL-27 et une bonne santé."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'IL-27 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques ciblant l'IL-27 sont en développement pour les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'IL-27 peut-elle être inhibée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des inhibiteurs spécifiques de l'IL-27 sont à l'étude pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels médicaments affectent l'IL-27 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments anti-inflammatoires peuvent moduler les niveaux d'IL-27."
}
},
{
"@type": "Question",
"name": "L'IL-27 est-elle une cible pour l'immunothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-27 est une cible potentielle pour l'immunothérapie dans le cancer."
}
},
{
"@type": "Question",
"name": "Comment l'IL-27 influence-t-elle les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-27 peut influencer l'efficacité des traitements en modulant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à l'IL-27 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés d'IL-27 peuvent entraîner des complications dans les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'IL-27 est-elle impliquée dans des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-27 est associée à des maladies chroniques comme l'arthrite et le lupus."
}
},
{
"@type": "Question",
"name": "Comment l'IL-27 affecte-t-elle le cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-27 peut avoir un rôle double dans le cancer, favorisant ou inhibant la croissance tumorale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'infection liés à l'IL-27 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés d'IL-27 peuvent augmenter le risque d'infections en modulant l'immunité."
}
},
{
"@type": "Question",
"name": "L'IL-27 est-elle liée à des troubles neurologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux d'IL-27 peuvent être associés à des troubles neurologiques comme la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent l'IL-27 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, l'obésité et les infections chroniques peuvent augmenter les niveaux d'IL-27."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux d'IL-27 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux d'IL-27 peuvent augmenter avec l'âge, affectant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies auto-immunes présentent souvent des niveaux élevés d'IL-27."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il l'IL-27 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter les niveaux d'IL-27 et aggraver l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'IL-27 et l'alimentation ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes alimentaires peuvent influencer les niveaux d'IL-27, notamment les régimes riches en sucres."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States.
Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States.
Publications dans "Interleukine-27" :
4 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States.
Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, USA.
Vaccine Development Center at West Virginia University Health Sciences Center, Morgantown, WV, USA.
Publications dans "Interleukine-27" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology, & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, USA.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Department of Haematology and Laboratory Sciences, School of Para-Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
National Centre for Cell Science, Pune, India.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
National Centre for Cell Science, Pune, India.
Trident Academy of Creative Technology, Bhubaneswar, India.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Tianjin Medical University General Hospital Airport Hospital, Tianjin, China.
Publications dans "Interleukine-27" :
2 publications dans cette catégorie
Affiliations :
Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Publications dans "Interleukine-27" :
Advances in neurotechnologies are revolutionizing our understanding of complex neural circuits and enabling new treatments for disorders of the human brain. In the vestibular system, electromagnetic s...
In this narrative review, we describe evolving neuromodulatory techniques including magnetic vestibular stimulation (MVS), deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), and tr...
MVS triggers both vestibular nystagmic (persistent) and perceptual (lasting ∼1 min) responses that may serve as a model to study central adaptational mechanisms and pathomechanisms of hemispatial negl...
Neuromodulation has a bright future as a potential treatment of vestibular dysfunction. MVS, DBS and TMS may provide new and sophisticated, customizable, and specific treatment options of vestibular s...
Transcranial magnetic stimulation is a safe, effective, and well-tolerated intervention for depression; it is currently approved for treatment-resistant depression. This article summarizes the mechani...
This pilot feasibility study aimed to evaluate the effects of transcranial magnetic stimulation (TMS) on chemotherapy-related cognitive impairment (CRCI), and we report here on the first patient....
Deleterious cognitive changes due to chemotherapy or CRCI are commonly referred to as "chemo brain". With the increasing survival of cancer patients, this poorly understood and inadequately treated co...
A 58-year-old woman, diagnosed 7 years prior with left breast cancer, underwent partial mastectomy with sentinel lymph node biopsy. She then received four cycles of adjuvant chemotherapy followed by r...
This first patient in the phase 1 clinical trial testing of TMS for the treatment of "chemo brain" provided important lessons for feasibility and insights into mechanisms of potential benefit....
Obsessive-compulsive disorder (OCD) patients need novel therapeutic interventions since most experience residual symptoms despite treatment. Converging evidence suggest that OCD involves dysfunction o...
We describe a routine to precisely localize cortical muscle representations within the primary motor cortex with transcranial magnetic stimulation (TMS) based on the functional relation between induce...
Personalized treatments are gaining momentum across all fields of medicine. Precision medicine can be applied to neuromodulatory techniques, in which focused brain stimulation treatments such as repet...
Repetitive paired-pulse transcranial magnetic stimulation (iTMS) at indirect (I) wave intervals increases motor-evoked potentials (MEPs) produced by transcranial magnetic stimulation (TMS) to primary ...
Eighteen young adults (aged 24.6 ± 4.2 years) participated in four sessions in which iTMS targeting early (1.5-millisecond interval; iTMS...
MEP amplitude was increased after iTMS (p < 0.01), and this was greater for PA responses (p < 0.01) but not different between iTMS intervals (p = 0.9). Irrespective of iTMS interval and coil current, ...
The timing of iTMS failed to influence which I-wave circuits were potentiated by the intervention. In contrast, decreases in the N45 suggest that the neuroplastic effects of iTMS may include disinhibi...
Noninvasive brain stimulation and neuroimaging have revolutionized human neuroscience with a multitude of applications, including diagnostic subtyping, treatment optimization, and relapse prediction. ...
Multiple sclerosis (MS) is a common chronic, autoimmune-mediated inflammatory and neurodegenerative disease of the central nervous system. The treatment of MS has enormous progress with disease-modify...
The use of Transcranial Magnetic Stimulation (TMS) in the add-on treatment of patients with treatment-resistant depression (TRD) is becoming more common. This study aims to investigate the efficacy of...
The current study was conducted with 38 patients diagnosed with TRD. The patients were randomly divided into two groups and received 20 sessions of high-frequency (10Hz) TMS and 20 sessions of sham TM...
A statistically significant decrease was found in the HAM-D and HAM-A in the group who were actively stimulated in the cross-over phase of the study. While there was a significant decrease in the HAM-...
This randomized, double-blind, sham-controlled, cross-over study revealed that TMS is superior to sham-TMS, provides clinically significant improvement when implemented besides pharmacotherapy among p...